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Summary Decreased membrane rigidity is one of the characteristics of malignant cells, resulting in part from
the desaturation of stearic acid into oleic acid. In this study we investigated the influence of stearic acid on
tumour cell inhibition in vitro and tumour development in vivo. Stearic acid inhibited the colony-forming
ability of 4 out of 5 rat and two human tumour continuous cell lines in vitro. In contrast, the colony-forming
ability of rat fibroblasts was not inhibited and that of human foetal lung fibroblasts was inhibited at a higher
dose than that required to inhibit human tumour cell lines. Using a model of rat mammary carcinoma
induced by nitroso-methyl urea (NMU) the subcutaneous injection of stearic acid at weekly intervals
prevented tumour development in 5 to 10 rats. Using iodostearic acid twice weekly, 11 of 19 rats were alive
and tumour free at week 22 whilst all of 14 animals injected with NMU alone had died of tumour by the 16th
week. The ratio of stearic to oleic acids in erythrocyte membranes was significantly reduced in the tumour-
bearing rats, but was normal in tumour-free animals treated with stearic or iodostearic acid. These
preliminary data indicate that stearic acid inhibits tumour development in rats.
The regulation of membrane rigidity is essential for
homeostasis (Cooper, 1977) and the metabolic rates of many
essential cell enzymes depend on it (Sandemann, 1979). In
general, decreased membrane rigidity leads to increased cell
metabolism and also higher division rates, features charac-
teristic of the malignant cell. Corvin et al. (1977) have also
shown that alteration of membrane lipid structure may
change the cancer cell phenotype. The evidence for decreased
membrane rigidity in malignant cells is derived from direct
physical measurements and lipid analysis. Using fluorescent
probes and magnetic resonance studies, decreased micro-
viscosity (decreased membrane rigidity) was found in plasma
membranes, as well as in isolated lipid vesicles from
leukaemic cells (Petitou et al., 1978; Mountford et al., 1986).
Fatty acid analysis of lipids extracted from transformed cells,
cell lines, leukaemic cells and solid tumour tissue showed a
consistent increase in the oleic acid content relative to stearic
acid (Apostolov et al., 1985; Wood et al., 1985).
The normal metabolic flow results in conversion of the
saturated stearic acid to the monounsaturated oleic acid by
the enzyme complex delta 9 desaturase. The ratio of stearic
to oleic acid, the so-called saturation index (SI), reflects the
activity of this enzyme (Wood et al., 1985). A significant
decrease in the SI of red blood cell membranes was noted in
a range of human (Wood et al., 1985) and animal
malignancies (Habib et al., 1987b), and it was suggested that
this index could be used as a tumour marker. It has also
been reported that there is a decrease in the SI of red blood
cell membranes in patients suffering from the Acquired
Immune Deficiency Syndrome (Apostolov et al., 1987).
We have noted previously that interferon inhibits the
desaturation of stearic acid in vitro (Apostolov & Barker,
1981) and that interferon treatment of patients with hairy
cell leukaemia leads to improvement in the saturation index
in proliferative blood cells (Worman et al., 1987). It has been
suggested that one of the biological activities of interferon
could be the inhibitory effect on delta 9 desaturase and
subsequent increase in stearic acid and membrane rigidity
(Apostolov & Barker, 1981). These findings prompted the
study of the possible use of exogenous stearic acid to prevent
or reverse the desaturation of cell membrane stearic acid and
thereby inhibit cell division both in vitro and in vivo.
Materials and methods
Clonogenic assays
Assessment of tumour cell inhibition by stearic acid was
measured using both rat and human cell lines by clonogenic
assay. Cells from rat mammary carcinoma (Sp22), primary
rat fibroblasts (from alveolar tissue) and 4 rat hepatoma cell
lines (D23, D261, D262A and D262B) were studied by one
of us (MJE).
The method used for rat cells was as follows: 200 cells
were plated per dish in ml (Eagles' methionine enriched
medium (MEM)+ 10% newborn calf serum (NBCS) in
30mm culture dishes and incubated for 4h at 37°C. All
became firmly adherent during this initial incubation. Stock
solution of stearic acid at 10 mgml - 1 in ethanol was
prepared and added to MEM +NBCS at the level of 1%
ethanol lOO1jg- ml- 1 stearic acid. Dilutions containing
20ugml-1, 2igml-1, 200ngml- 1 and 2ngml - were
prepared. One ml of each dilution was added to 4 dishes of
cells, the final concentration being half the concentration of
the material added. At the highest stearic acid concentration
the ethanol concentration was 0.5%. To control dishes 1 ml
of MEM +NBCS was added, or 1 ml of MEM +NBCS + 1%
ethanol. The dishes were incubated for 5 days. Medium was
then removed, and the cell colonies were rinsed with 0.9%
W/V NaCl solution and fixed for 15min with methanol. Cell
colonies were stained with 1 % aqueous crystal violet and the
dishes allowed to dry. Colonies were counted under a
stereoscopic microscope, and colony formation at each
stearic acid concentration was expressed as a percentage of
that in the medium control (100%).
The human tumour cell lines were studied in another
laboratory (BF, WEJ and JRWM). The method for human
tumour cell lines was as follows: 500 exponentially-growing
RT112 (transitional cell carcinoma of the bladder) cells or
two hundred 833 K (non-seminomatous testicular germ cell
tumour) cells or 600 human foetal lung fibroblasts (HFL)
cells were plated in 5 cm dishes in RPM11640 medium
supplemented with 5% foetal calf serum and 2mm 1-
glutamine. After 48 h culture this was replaced with fresh
medium alone or medium containing stearic acid. The stearic
acid was dissolved in ethanol and diluted in medium to give
final concentrations of between 1-12,ugml-1. Following a
further 14 days incubation colonies were fixed, stained and
counted. Colony-forming efficiency of the treated cells was
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expressed as a proportion of that in the controls. The
experiments were repeated three times to permit statistical
analysis.
In vivo experiment with stearic acid
To study the influence of stearic acid in vivo, an established
animal model was used. N-nitrosomethyl urea (NMU)
rapidly induces mammary carcinoma in rats (Chan et al.,
1977; Gullino et al., 1975) and does not require metabolic
activation (Preussmann & Stewart, 1984).
Thirty female Sprague-Dawley rats weighing -200g each
were divided into 2 groups. The first (n=20) received NMU
only, the second (n= 10) received NMU plus stearic acid.
NMU in 3% acetic acid (Sigma Chemicals, UK) was
dissolved in distilled water (20mgml-1) and was given in
three i.v. injections of 5mg 100g1 body wt, at weeks 1, 4
and 8. Stearic acid (Sigma Chemicals, UK) (0.5mg)
dissolved in liquid paraffin (0.5ml) was injected at weekly
intervals s.c. in the flank, starting from the second week. The
parenteral route of administration was preferred for our
study in order to avoid first call metabolism by the liver of
orally-administered lipids.
The onset of tumours was monitored by daily inspection
and by palpation of the mammary regions twice weekly. At
week 22 of the experiment, all surviving animals were
sacrificed, autopsies were performed and the tumours were
dissected and examined histologically.
In vivo experiment with iodostearic acid
A similar investigation was performed using iodostearic acid
in place of stearic acid, since it is more readily soluble in
lipid solvent than the parent compound. Oleic acid was
commercially purchased (Sigma Chemicals, UK) and
iodinated by passing dry hydrogen iodide gas in nitrogen
through oleic acid at 4°C. Excess iodine was removed at the
end of the reaction by the addition of an excess of sodium
thiosulphate. The product of these reactions was a mixture
of 9 iodo-octadecanoic, 10 iodo-octadecanoic and 9, 10 di-
iodo-octadecanoic acids. These can be collectively referred to
as iodinated stearic acid.
Fifty-nine female Sprague-Dawley rats weighing - 200g
each were divided into 3 groups. The first group (n = 15) was
injected with NMU alone. The second group (n=21)
received NMU and alpha2 interferon (Schering). The third
group (n=23) received NMU plus iodostearic acid dissolved
in liquid paraffin. NMU in 3% acetic acid was dissolved in
distilled water (20mgml-1) and given in two i.v. injections
of 7mg 100g 1 body wt, the second injection following three
weeks after the first. Alpha2 interferon was administered i.m.
in a dose of 80,000IUkg-1 twice each week throughout the
experiment. lodostearic acid was given s.c. in a dose of
0.5mg twice a week throughout the experiment starting from
the 5th week.
Tumour onset was monitored as in the previous
experiment. Throughout the experiment only rats that had
ulcerated tumours or developed cachexia and marked
weakness were sacrificed.
Gas-liquid chromatography analysis ofrat erythrocytes
When rats were killed, blood was withdrawn via cardiac
puncture and collected in EDTA bottles. Blood was
withdrawn from living rats (without tumour) via the tail
vein. The aim of this investigation was two-fold. First, to
study the possible reduction of stearic to oleic acid ratio in
the erythrocytes of rats during chemical carcinogenesis.
Second, to investigate whether iodostearic acid inhibited the
stearic acid desaturation phenomenon in the tumour-free
animals.
Rat erythrocytes were separated by centrifugation. Total
lipid extraction was carried out following the method
described by MacGee (1974). The extracts were analysed
blind using temperature-programmed (160°C to 260°C at 40
per min) gas liquid chromatography of the fatty acid methyl-
esters utilising a 2.1 mm x 2m ID glass column packed with
3% SP-2310/2% SP-2300 on 100/120 mesh chromosorb W
(Supelco Inc). Using this method it was possible to separate
C16, C18, C20 and C22 fatty acids. The ratio of stearic:
oleic fatty acids was taken from the GLC tracing and was
expressed as the saturation index (SI). Comparison of indices
was made using the Mann-Whitney test.
Results
Clonogenic assays
Table I demonstrates that stearic acid at a dose of
10pgml 1, caused significant inhibition of colony formation
in the 4 rat hepatoma cell lines. It failed to inhibit mammary
carcinoma (Sp22) or primary fibroblast colony development.
Table II shows that stearic acid inhibited colony formation
by the human 833 K, RTI 12 and HFL cell lines, in ti dose-
related fashion The ID 70 (i.e., dose needed to cause 70%
colony formation inhibition) were 2.8, 3.2 and 8.6pgml -
for the 833 K, RTI12 and HFL cells lines respectively.
In vivo experiment with stearic acid
Nineteen of the 20 rats in the NMU alone group developed
mammary tumours by week 16 of the experiment, with a
mean latent period of 72 days. These 19 rats had a total of
51 tumours, giving a mean of 2.68 tumours/rat, range 1-5.
The range of tumour weight/rat was 5g to 47.8g with a
mean of 23.6/rat, excluding the tumour free rats.
Five of the 10 rats in the NMU plus stearic acid group
developed mammary tumours by week 16 of the experiment,
with a mean latent period of 74 days. These 5 rats had 7
tumours between them, with a mean of 1.4 tumours/rat
(compared to NMU alone group P<0.001). The range of
tumour weight/rat was 4.2g to 21.2g, with an average of
16.4g/rat (P<0.01 compared to NMU alone group). By
week 22, 19 of the 20 rats in the NMU group were dead
with tumours, in contrast with only 2 of 10 rats in the
NMU+stearic acid group. Of the remaining 8 that were
killed, only 3 had tumours and 5 were tumour-free.
All tumours were examined histologically and were adeno-
carcinomas.
In vivo experiment with iodostearic acid
Figure I shows the results of this experiment. In the NMU
alone group one rat died following the first injection of
carcinogen. Of the remaining 14 animals, all developed
tumours with a mean latent period of 74 days. These rats
had 54 tumours between them, giving a mean of 3.8
tumours/rat (range 1-6). Tumour weight/rat ranged from 5g
to 53.5g with a mean of 23.6g tumour/rat.
Two rats in the NMU plus interferon group died
following carcinogen injection. All the remaining 19 rats
developed tumour, with a mean latent period of 77 days.
The rats with tumour had 63 tumours between them (range
Time (weeks)
Figure I Percentage of tumour free animals in relation to
treatment: NMU; 0 NMU+interferon; NMU+iodostearic acid.STEARIC ACID AND CARCINOGENESIS 457
Table I Tumour cell colony inhibition test by stearic acid using rat cell lines.
% colony
formation
Mean no % plating relative to P
Target cells Treatment colonies+SE efficiency medium control valuea
Sp22
Rat
mammary
carcinoma
Primary
rat
fibroblasts
(from
alveolar
tissue)
medium control
0.5% ethanol
stearic acid
medium control
0.5% ethanol
stearic acid
D23 medium control
Rat hepatoma 0.5% ethanol
stearic acid
D261 medium control
Rat hepatoma 0.5% ethanol
stearic acid
D262A medium control
Rat hepatoma 0.5% ethanol
stearic acid
D262B medium control
Rat hepatoma 0.5% ethanol
stearic acid
aSignificance
Significant.
I ngml-
lOngml-1
100ngml-
1 pgml-
lopgml-1
50pgml-1
1 ngml-
lOngml-P
lOOngml-1
Ijgml-
lOpgml-P
50pgml-
lOngml-P
lOOngml-1
1 p,gml- I
lOpgml-1
50pgml-1
1 pgml-
lOpgml-1
SOpgml-1
10ngml
100ngml-
1 pgml
10jugml
50pgml-
lOngml-1
lOOngml-1
I jigml-
lOpgml-1
50 pgml-
61.0+ 6
61.5+ 4
54.0+10
55.7+ 3
52.5+ 6
56.7+ 3
58.7+ 1
51.2+ 6
55.0+ 4.6
44.7+ 1.8
49.5+ 9.5
59.7+ 3.1
47.2+ 9.4
48.5+ 9.2
52.0+ 7.7
47.5+ 6.0
41.8 + 3.5
46.5+ 1.1
42.3+ 1.6
37.0+ 1.5
28.0+ 1.5
28.0+ 2.9
10.0+ 2.6
33.0+ 5.1
30.0+ 2.4
21.0+ 3.0
18.0+ 1.5
6.0+ 3.0
245.0+11.9
236.7+ 8.2
216.0+ 8.8
247.8+ 8.3
203.8+18.1
190.3 + 13.6
79.3+ 7.1
37.0+ 4.0
34.0+ 9.5
40.3 + 1.8
41.0+ 1.8
31.0+ 5.8
25.0+ 2.8
18.0+ 4.5
30.5
30.7
27.0
27.8
26.2
28.3
29.3
25.6
27.9
22.3
24.7
29.8
23.6
24.2
26.0
23.7
20.9
23.2
21.1
17.5
14.0
14.0
5.0
16.5
15.0
10.6
9.0
3.0
122.5
118.3
108.0
123.9
101.9
95.2
39.6
18.5
17.0
20.1
20.5
15.5
12.5
9.0
83
91
86
93
96
84
90.0
108.5
85.8
88.2
96.5
86.4
101.2
88.5
67.0
67.0
23.9
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
<0.02
<0.02
<0.03
64.5 <0.05
54.5 <0.01
18.1 <0.001
88.0 NS
101.1 NS
83.2 NS
74.7 <0.05
32.4 <0.002
108.9 NS
110.8 NS
83.8 NS
67.6 <0.05
48.6 <0.02
of difference between treated dishes and medium controls (student t-test); NS =No
Table II Tumour cell colony inhibition test by stearic acid using
human cell lines.
Colony-forming (+standarderror)
Stearic acid
concentration RTJ12 833K HFL
1 92.0%+ 13.5 81.5% + 3.0
2 86.0% +10.5 70.4% +12.0 101.3% +9.3
4 45.0%+ 6.6 27.5%+ 2.0 103.1%+8.8
6 4.6%+ 0.7 0.9%+ 0.5 92.8%+5.9
8 0.3%+ 0.3 0% 77.3%+6.0
10 0% 0% 10.5%+2.5
12 0% 0% 0%
1-6) with a mean of 3.3 tumours/rat. Tumour weight/rat
ranged from 3.8 g to 34.5 g with a mean of 19g/rat. None of
these results were appreciably different from controls.
In the NMU group treated with iodostearic acid, 4 rats
died following carcinogen injection. Of the remaining 19 rats,
8 developed tumour with a mean latent period of 76 days.
The 8 rats had a mean of 2.7 tumours/rat, with a range of
1-5. Four had extensive tumours (>4cm diam.), and 2 had
tumours between 2-4 cm. The remaining two rats had
massive tumours (>4cm) which regressed subsequently to
less than 2 cm on continued treatment with iodostearic acid.
At week 22, eleven of the 19 rats treated with NMU plus
iodostearic acid were still alive and without tumour.
All the tumours examined histologically were adeno-
carcinomas.
Gas-liquid chromatography analysis ofrat erythrocytes
Figure 2 shows the mean and standard deviation of the SI in
each group of rats. The mean SI of the normal saline group
was 2.0+0.3. In the NMU group, the erythrocyte SI fell
consistently in all rats (P<0.001) to a mean of 1.09+0.28.
Similarly, the SI was significantly reduced in rats receiving
interferon (mean = 1.1 +0.16). By contrast, those rats
receiving iodostearic acid that were tumour-free had an SI of
2.12+0.42. Moreover, the tumour-bearing animals receiving
iodostearic acid had an SI (mean 1.79+0.33) that was higher
than the group with NMU alone (P<0.002), but lower than
that of tumour-free animals.
Discussion
This study has shown that stearic acid significantly inhibits
the colony-forming ability of some tumour cell lines, in a
t
1
1
1
1
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3.0-
2.0
1.0
Control NMU NMU NMU
alone + +
I'Stearic; I'Stearic;
No. Tumour + Tumour
Figure 2 Changes in saturation index of red blood cell
membranes.
dose-related manner. Although human cancer cells appear
more sensitive to stearic acid than rat cancer cells, the
methodology and culture conditions differed. Other workers
have shown a similar effect in vitro with a non selective
incorporation of fatty acids into cell phospholipids (Doi et
al., 1978; Wicha et al., 1979). In those studies the addition of
oleic acid had either no effect or stimulated cell division. An
important feature of our work has been the demonstration
that parenteral administration of stearic acid in vivo can
prevent the development of tumours in an experimental
animal model. We have also provided indirect evidence that
inhibition of mammary carcinogenesis is linked to the
maintenance of a normal saturation index within the cell
membranes. By preserving the ratio of saturated to
unsaturated fatty acid, the membrane rigidity remains
normal and cell division is inhibited. Those animals that
developed tumours despite treatment with stearic acid had
significantly fewer and smaller tumours than the animals
given carcinogen alone. Their saturation index in erythrocyte
membranes was lower than that of tumour-free animals, but
was still significantly higher than that of rats given
carcinogen without stearic acid. These observations on the
erythrocyte saturation index were the same whether the rats
were injected with stearic acid or iodostearic acid (data not
included).
We have previously shown (Wood et al., 1985) that a
decrease in the saturation index of red blood cell membranes
is a characteristic finding in patients with a variety of
cancers. That this is a reversible change is shown by the
return to normal of the saturation index after surgical
excision of the tumour, and a subsequent fall with tumour
recurrence. Erythrocytes were chosen because they are end-
stage non-dividing cells with only one plasma membrane.
The extraction procedure used measured the total fatty lipids
of the cell membrane rather than the free fatty acids. We
have also shown that the drop in saturation index of
erythrocytes observed in human cancer can also be seen in
rats developing colonic carcinomas following exposure to
dimethylhydrazine (Habib et al., 1987b), but does not occur
in rats with nutritional cachexia (unpublished observation).
Similar changes in cell membrane lipid composition also
occur in human leucocytes and platelets in cancer patients
(Apostolov et al., 1985), suggesting the presence of a
desaturation producing factor (DPF) released by the tumour
(Habib et al., 1987a). We therefore postulate that an
alteration in the fatty acid composition of cell membranes
may play a role in the carcinogenic process (Habib et al.,
1987b).
The ability to prevent the alteration in the ratio of fatty
acids, as suggested by this study, may either inhibit or
merely delay primary oncogenesis. It remains to be shown
whether stearic or iodostearic acid have a direct effect on the
erythrocyte cell membranes or whether the response is
secondary to changes in the bone marrow. It is interesting to
note that in two rats tumours actually regressed with
continued stearic acid therapy. If confirmed, this finding
raises the possibility that in addition to inhibiting cell
division, altering the fatty acid structure of the membrane
may have a direct anti-tumour effect. Future work will
investigate the role of stearic acid and its derivatives in the
treatment of neoplasia by studying the effect on established
tumours growing as transplants.
Our thanks to Miss K. Bradley for typing the manuscript.
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